Form 4 for BSX Boston Scientific
Accepted 2024-05-23 00:00:00 ET · period of report 2024-05-21 · accession 0001225208-24-006324 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2024-05-23 | 2024-05-21+ | BSX | Brown Vance R | SVP, GC, Corp. Sec | S - Sale+OE | $75.79 | -33.0K | 32.3K | -51% | -$2.50M |
| DM | 2024-05-23 | 2024-05-21+ | BSX | Brown Vance R | SVP, GC, Corp. Sec | M - OptEx | $25.70 | +33.0K | 50.4K | +191% | +$849.3K |
| DM | 2024-05-23 | 2024-05-21+ | BSX | Brown Vance R | SVP, GC, Corp. Sec | M - OptEx | $0.00 | -33.0K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-05-22 | S | D | 15,006 | $76.01 | 32,326 | D | — | — | (F3) Represents the weighted average sale price. These shares were sold in multiple transactions at prices ranging from $75.7650 to $76.22, inclusive. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. |
| 2 | Common | Common Stock | 2024-05-22 | M | A | 15,006 | $27.09 | 47,332 | D | — | — | |
| 3 | Common | Common Stock | 2024-05-21 | S | D | 18,037 | $75.60 | 32,326 | D | — | — | (F2) Represents the weighted average sale price. These shares were sold in multiple transactions at prices ranging from $75.505 to $75.74, inclusive. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. |
| 4 | Common | Common Stock | 2024-05-21 | M | A | 18,037 | $24.55 | 50,363 | D | — | — | |
| 5 | Derivative | Stock Option (Right to Buy) | 2024-05-22 | M | D | 15,006 | $0.00 | 0 | D | $27.09 · — to 2028-02-15 | 15,006 Common Stock | (F5) Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on February 15, 2019, the first anniversary of the date of grant. |
| 6 | Derivative | Stock Option (Right to Buy) | 2024-05-21 | M | D | 18,037 | $0.00 | 0 | D | $24.55 · — to 2027-02-28 | 18,037 Common Stock | (F4) Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on February 28, 2018, the first anniversary of the date of grant. |